Beatriz López-Calviño

Beatriz López-Calviño

Auto-generated profile, based on publicly available information

Beatriz López-Calviño

Clinical Epidemiology and Biostatistics Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), SERGAS, Universidade da Coruña, A Coruña, Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2014 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
SPS. Pita-Fernández
S. Pita-Fernández
MAM. Alhayek-Aí
M. Alhayek-Aí
CGC. González-Martín
C. González-Martín
BLB. López-Calviño
B. López-Calviño
TSTeresa Seoane-Pillado
Teresa Seoane-Pillado
SPS. Pértega-Díaz
S. Pértega-Díaz
A wide variety of follow-up strategies are used for patients with colorectal cancer (CRC) after curative surgery. The aim of this study is to review the evidence of the impact of different follow-up strategies in patients with nonmetastatic CRC after curative surgery, in relation to overall survival and other outcomes. A systematic search of PubMed, EMBASE, SCOPUS and ISI Web of Knowledge up to June 2014 was carried out. Eligible studies were all randomized clinical trials comparing the effectiveness of different follow-up strategies after curative resection in nonmetastatic CRC. Eleven studies with n = 4055 participants were included in a meta-analysis. A significant improvement in overall survival was observed in patients with more intensive follow-up strategies [hazard ratio = 0.75; 95% confidence interval (CI) 0.66–0.86]. A higher probability of detection of asymptomatic recurrences [relative risk (RR) = 2.59; 95% CI 1.66–4.06], curative surgery attempted at recurrences (RR = 1.98; 95% CI 1.51–2.60), survival after recurrences (RR = 2.13; 95% CI 1.24–3.69), and a shorter time in detecting recurrences (mean difference = −5.23 months; 95% CI −9.58 to −0.88) was observed in the intervention group. There were no significant differences in the total tumor recurrences, nor in the mortality related to disease. Intensive follow-up strategies improve overall survival, increase the detection of asymptomatic recurrences and curative surgery attempted at recurrence, and are associated with a shorter time in detecting recurrences. This more intensive follow-up could not be associated with an improvement in cancer-specific survival nor with an increased detection of total tumor recurrences. Follow-up with serum carcinoembryonic antigen and colonoscopies are related to an increase in overall survival.

1 January 2015 in Journal of Epidemiology
Verified
Journal Article
Open access
SPSalvador Pita-FernÁNdez
Salvador Pita-FernÁNdez
CGCristina Gonzalez-Martin
Cristina Gonzalez-Martin
TSTeresa Seoane-Pillado
Teresa Seoane-Pillado
BLBeatriz LÓPez-CalviÑO
Beatriz LÓPez-CalviÑO
SPSonia PÉRtega-DÍAz
Sonia PÉRtega-DÍAz
VGVicente F. Gil-Guillen
Vicente F. Gil-Guillen
Research is needed to determine the prevalence and variables associated with the diagnosis of flatfoot, and to evaluate the validity of three footprint analysis methods for diagnosing flatfoot, using clinical diagnosis as a benchmark. We conducted a cross-sectional study of a population-based random sample ≥ 40 years old (n = 1002) in A Coruña, Spain. Anthropometric variables, Charlson's comorbidity score, and podiatric examination (including measurement of Clarke's angle, the Chippaux-Smirak index, and the Staheli index) were used for comparison with a clinical diagnosis method using a podoscope. Multivariate regression was performed. Informed patient consent and ethical review approval were obtained. Prevalence of flatfoot in the left and right footprint, measured using the podoscope, was 19.0% and 18.9%, respectively. Variables independently associated with flatfoot diagnosis were age (OR 1.07), female gender (OR 3.55) and BMI (OR 1.39). The area under the receiver operating characteristic curve (AUC) showed that Clarke's angle is highly accurate in predicting flatfoot (AUC 0.94), followed by the Chippaux-Smirak (AUC 0.83) and Staheli (AUC 0.80) indices. Sensitivity values were 89.8% for Clarke's angle, 94.2% for the Chippaux-Smirak index, and 81.8% for the Staheli index, with respective positive likelihood ratios or 9.7, 2.1, and 2.0. Age, gender, and BMI were associated with a flatfoot diagnosis. The indices studied are suitable for diagnosing flatfoot in adults, especially Clarke's angle, which is highly accurate for flatfoot diagnosis in this population.

15 May 2015 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
JGJorge González‐Zabaleta
Jorge González‐Zabaleta
SPSalvador Pita‐Fernandez
Salvador Pita‐Fernandez
TSTeresa Seoane-Pillado
Teresa Seoane-Pillado
BLBeatriz López‐Calviño
Beatriz López‐Calviño
JGJose Luis Gonzalez‐Zabaleta
Jose Luis Gonzalez‐Zabaleta

22 August 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SPSalvador Pita-Fernández
Salvador Pita-Fernández
LGLuis González-Sáez
Luis González-Sáez
BLBeatriz López-Calviño
Beatriz López-Calviño
TSTeresa Seoane-Pillado
Teresa Seoane-Pillado
ERElena Rodríguez-Camacho
Elena Rodríguez-Camacho
SDSonia Pertega Diaz
Sonia Pertega Diaz
Disparate and contradictory results make studies necessary to investigate in more depth the relationship between diagnostic delay and survival in colorectal cancer (CRC) patients. The aim of this study is to analyse the relationship between the interval from first symptom to diagnosis (SDI) and survival in CRC. Retrospective study of n = 942 CRC patients. SDI was calculated as the time from the diagnosis of cancer and the first symptoms of CRC. Cox regression was used to estimate five-year mortality hazard ratios as a function of SDI, adjusting for age and gender. SDI was modelled according to SDI quartiles and as a continuous variable using penalized splines. Median SDI was 3.4 months. SDI was not associated with stage at diagnosis (Stage I = 3.6 months, Stage II-III = 3.4, Stage IV = 3.2; p = 0.728). Shorter SDIs corresponded to patients with abdominal pain (2.8 months), and longer SDIs to patients with muchorrhage (5.2 months) and rectal tenesmus (4.4 months). Adjusting for age and gender, in rectum cancers, patients within the first SDI quartile had lower survival (p = 0.003), while in colon cancer no significant differences were found (p = 0.282). These results do not change after adjusting for TNM stage. The splines regression analysis revealed that, for rectum cancer, 5-year mortality progressively increases for SDIs lower than the median (3.7 months) and decreases as the delay increases until approximately 8 months. In colon cancer, no significant relationship was found between SDI and survival. Short diagnostic intervals are significantly associated with higher mortality in rectal but not in colon cancers, even though a borderline significant effect is also observed in colon cancer. Longer diagnostic intervals seemed not to be associated with poorer survival. Other factors than diagnostic delay should be taken into account to explain this “waiting-time paradox”.

1 January 2015 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
JGJorge González-Zabaleta
Jorge González-Zabaleta
SPSalvador Pita-Fernandez
Salvador Pita-Fernandez
TSTeresa Seoane-Pillado
Teresa Seoane-Pillado
BLBeatriz López-Calviño
Beatriz López-Calviño
JGJose Luis Gonzalez-Zabaleta
Jose Luis Gonzalez-Zabaleta

10 January 2011 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
SPSalvador Pita-Fernández
Salvador Pita-Fernández
SDSonia Pertega Diaz
Sonia Pertega Diaz
FVFrancisco Valdés-Cañedo
Francisco Valdés-Cañedo
RSRocio Seijo-Bestilleiro
Rocio Seijo-Bestilleiro
TSTeresa Seoane-Pillado
Teresa Seoane-Pillado
ALAndres López-Muñiz
Andres López-Muñiz
Cardiovascular disease (CVD) is the major cause of death after renal transplantation. Not only conventional CVD risk factors, but also transplant-specific risk factors can influence the development of CVD in kidney transplant recipients.